Zydus Cadila to get clarity on ZyCoV-D Covid vaccine pricing in 1-2 weeks: MD Sharvil PatelOn Sunday, news wire PTI reported, citing government sources, that the company had agreed to bring down the price of ZyCov-D to ₹265 a dose...
First children-friendly Covid vaccination centreFor more such web stories click on the ET icon below.
Govt finalises price of Cadila's child Covid vaccine ZyCoV-D, rollout likely soonAccording to sources, the government has negotiated the pricing of the vaccine which is "much lower than what the manufacturers had demande...
India says government panel looking into new Delta subvariantA panel of experts set up by the Indian government is looking into a Delta coronavirus subvariant that has been detected in the UK
Zydus Cadila proposes Rs 1900 for three-dose COVID vaccine; Govt negotiating to bring it downThe government had on Thursday said that the indigenously-developed, world's first DNA-based needle-free COVID-19 vaccine by Zydus Cadila w...
Government lab releases first batch of Zydus Cadila's covid vaccine ZyCoV-DNeedle-free ZyCoV-D, manufactured by Ahmedabad-based Zydus Cadila, is the first Covid-19 vaccine approved for the 12 to 18 years age group ...
Government may earmark a part of Zydus vaccine for sick kidsThe drug regulator had last week approved ZyCov-D, the world’s first DNA-based vaccine against the novel coronavirus, for emergency use in ...
NTAGI to soon chalk out roadmap to introduce Zydus Cadila's vaccine in Covid inoculation driveThe indigenously developed world's first DNA-based needle-free COVID-19 vaccine ZyCoV-D received Emergency Use Authorisation from the drug ...
Zydus Cadila seeks approval for its needle-free COVID vaccine ZyCOV-D; here's how it worksAccording to a TOI report, Ahmedabad-based Zydus Cadila, which is also one of the companies developing coronavirus vaccine, has sought emer...
India's Zydus Cadila applies for emergency use nod for COVID-19 vaccineCoronavirus cases in India dropped from a devastating peak in April and May, however, experts have warned of a third wave and reiterated th...
Zydus to seek emergency nod for Covid vaccine soonThe company is expected to present phase III data for ZyCoV-D--a plasmid DNA vaccine—to the country’s drug regulatory authority by next wee...
Zydus Cadila likely to seek emergency use authorisation for its Covid vaccine next weekPharmaceutical major Zydus Cadila has told the Centre that it could apply for emergency use authorisation (EUA) for ZyCoV-D vaccine in the ...
View: How Department of Biotechnology coordinated India's Covid-19 fightFrom its initial mandate to identify priority development areas in biotechnology, it has been instrumental in creating an academic ecosyste...
Cadila Healthcare Working on Needle-free, 2-Dose VaccineThe drug company is conducting phase-3 trials with over 20,000 participants to test whether its three-dose vaccine ZyCoV-D prevents virolog...
COVID-19 vaccine approval: All risks paid off, proud moment for India, say SII, Bharat BiotechPune-based vaccine major Serum Institute of India (SII) had entered into a collaboration with the University of Oxford and AstraZeneca to m...
Zydus Cadila seeks govt nod to start Phase-III clinical trials of COVID-19 vaccineThe Phase-II study of the vaccine, ZyCoV-D, had been conducted in over 1,000 healthy adult volunteers as part of the adaptive Phase-I and I...
Gujarat: PM Modi reviews vaccine development at Zydus Cadila facilityAfter his arrival at Ahmedabad airport from Delhi shortly after 9 am, Modi flew to the Zydus Cadila plant and held discussions with the pro...